The FDA sets a regulatory speed record, providing a snap OK for Vertex's breakthrough triplet for cystic fibrosis
The FDA has approved Vertex’s new triplet for cystic fibrosis at a record-setting speed.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
